Effects of Protein Type and Mineral Form on Amino Acid Availability (ProMin)
Effects of Protein Type and Mineral Form on Postprandial Amino Acid Availability in Healthy Young Adults: a Randomized Cross-over Study
To compare postprandial plasma amino acid availability, expressed as incremental area under the curve (iAUC), over a 6 hour period following ingestion of 25 g of different protein isolates in healthy, young adults. The primary objective is divided into the following 2 sub-studies, each with 3 comparisons:
- Sub-study 1: whey protein, calcium caseinate, sodium caseinate.
- Sub-study 2: calcium caseinate, magnesium caseinate, potassium caseinate.
調査の概要
詳細な説明
All living tissues are in a constant state of protein turnover, with synthesis and breakdown processes ensuring structural integrity, metabolic flexibility and the capacity for repair. Amino acids are the building blocks of proteins and must be supplied through the diet to maintain a positive protein balance. Ingestion of high-quality protein sources (e.g. meat, dairy) leads to a postprandial increase in circulating amino acids, and as such can facilitate tissue protein synthesis. The magnitude and the kinetics of the amino acid response largely depend on the amino acid composition combined with protein digestion and amino acid absorption rate.
Beyond their structural role, amino acids also function as signalling molecules involved in gastrointestinal hormone secretion and appetite control. One such key hormone is glucagon-like peptide 1 (GLP-1), a gut-derived hormone that plays an essential role in metabolic regulation such as insulin secretion and appetite suppression. Given its role in metabolic health, particularly in the context of obesity and type 2 diabetes, increasing GLP-1 availability has become a target for support in metabolic care. However, many pharmacological approaches to elevate GLP-1 are costly and carry risks of harmful side-effects.
Nutritional strategies that modulate GLP-1 secretion and availability therefore offer an attractive alternative. Emerging evidence suggests that not only protein ingestion itself, but also the matrix in which the protein is delivered can modulate GLP-1 secretion. For example, co- ingestion of specific minerals, especially calcium, has been shown to enhance GLP-1 secretion beyond the effects of protein ingestion alone. These data indicate that mineral-protein interactions may play a meaningful role in appetite regulation and metabolic signalling, warranting further investigation.
Bovine milk contains two primary high-quality protein fractions: whey (~20%) and casein (~80 %). Whey protein is rapidly digested, resulting in fast but transient increases in circulating amino acids, whereas casein protein is digested more slowly, leading to more prolonged but sustained amino acid availability (13-15). To optimize the functional properties of casein, various processing techniques can be applied, including the formation of caseinate salts through binding casein with different minerals such as calcium, sodium, magnesium, and potassium. These caseinate forms differ in mineral composition, which may influence not only digestion and absorption kinetics, but also GLP-1 secretion capacity. Although the differences in digestion kinetics between whey and casein are well-established, a direct comparison of postprandial amino acid and GLP-1 responses following ingestion of whey versus various mineral-bound caseinates has not yet been performed.
研究の種類
入学 (推定)
段階
- 適用できない
連絡先と場所
研究連絡先
- 名前:Noortje Boot, MSc
- 電話番号:088-3887246
- メール:noortje.boot@maastrichtuniversity.nl
研究連絡先のバックアップ
- 名前:Luc van Loon, Prof., PhD
- 電話番号:043-3881397
- メール:l.vanloon@maastrichtuniversity.nl
研究場所
-
-
Limburg
-
Maastricht、Limburg、オランダ、6200
- Maastricht University Medical Centre
-
コンタクト:
- Luc van Loon, PhD
- 電話番号:043-3881397
- メール:l.vanloon@maastrichtuniversity.nl
-
-
参加基準
適格基準
就学可能な年齢
- 大人
健康ボランティアの受け入れ
説明
To be eligible to participate in this study, a participant must meet all of the following criteria:
- Male or female sex
- Aged between 18 - 35 years inclusive
- BMI between 18 - 30 kg/m2
- Healthy, recreationally active (exercise at least once per two weeks and a maximum of four days per week)
- No physical limitations (i.e., able to perform all activities associated with daily living independently)
A potential participant who meets any of the following criteria will be excluded from participation in this study:
- Intolerant to milk protein and/or dairy-based products
- Smoking regularly
- Diagnosed with gastro-intestinal disorders
- Diagnosed with metabolic disorders (e.g. diabetes)
- Diagnosed with musculoskeletal disorders
- Blood donation in the past 2 months
- Females: pregnancy
- Use of any medication known to affect protein metabolism (e.g. corticosteroids, non-steroidal anti-inflammatories or prescribed acne medications)
- Chronic use of gastric acid suppressing drugs (e.g. proton pump inhibitors, H2-antagonists)
研究計画
研究はどのように設計されていますか?
デザインの詳細
- 主な目的:基礎科学
- 割り当て:ランダム化
- 介入モデル:クロスオーバー割り当て
- マスキング:ダブル
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
アクティブコンパレータ:Whey protein
25 g whey protein isolate
|
25 g protein isolate, dissolved in 500 mL water
|
|
実験的:Sodium caseinate
25 g sodium caseinate protein
|
25 g protein isolate, dissolved in 500 mL water
|
|
実験的:Calcium caseinate
25 g calcium caseinate protein
|
25 g protein isolate, dissolved in 500 mL water
|
|
実験的:Magnesium caseinate
25 g magnesium caseinate protein
|
25 g protein isolate, dissolved in 500 mL water
|
|
実験的:Potassium caseinate
25 g potassium caseinate protein
|
25 g protein isolate, dissolved in 500 mL water
|
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Six-hour postprandial plasma total amino acid availability following ingestion of 25 grams of different protein isolates in healthy, young adults
時間枠:Six hours
|
Plasma total amino acid availability is expressed as the incremental area under the curve (iAUC) and compared between whey protein, calcium caseinate and sodium caseinate (sub-study 1) and between calcium caseinate, magnesium caseinate and potassium caseinate (sub-study 2).
|
Six hours
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Plasma essential amino acid concentrations
時間枠:Essential amino acid concentrations are derived from blood samples taken before beverage ingestion and during the six-hour postprandial time-period (at 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 300 and 360 minutes following beverage ingestion).
|
The summed measurement of histidine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine concentrations
|
Essential amino acid concentrations are derived from blood samples taken before beverage ingestion and during the six-hour postprandial time-period (at 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 300 and 360 minutes following beverage ingestion).
|
|
Non-essential amino acid concentrations
時間枠:Nonssential amino acid concentrations are derived from blood samples taken before beverage ingestion and during the six-hour postprandial time-period (at 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 300 and 360 minutes following beverage ingestion).
|
The summed measurement of alanine, arginine, aspartic acid, cysteine, glutamic acid, glycine, serine, tyrosine and valine concentrations
|
Nonssential amino acid concentrations are derived from blood samples taken before beverage ingestion and during the six-hour postprandial time-period (at 15, 30, 45, 60, 75, 90, 120, 150, 180, 210, 240, 300 and 360 minutes following beverage ingestion).
|
|
Plasma amino acid kinetics
時間枠:During the six-hour postprandial period
|
Compare peak plasma amino acid concentrations and the time to reach these peak concentrations of all individually measured amino acids
|
During the six-hour postprandial period
|
|
Circulating mineral concentrations
時間枠:During the six-hour postprandial period
|
Calcium, magnesium, sodium, potassium and parathyroid hormone concentrations
|
During the six-hour postprandial period
|
|
Glucagon-like peptide-1 concentrations
時間枠:During the six-hour postprandial period
|
Postprandial glucacon-like peptide-1 (GLP-1) concentrations
|
During the six-hour postprandial period
|
協力者と研究者
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。